News
Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...
The commonly prescribed blood thinner clopidogrel should replace aspirin as a routine pill for preventing heart attacks and ...
Emerging evidence suggests a better option already exists. A recent meta-analysis by an international team of cardiologists ...
Discover Magazine on MSN
More Effective and Safe Blood Thinning Drug May Soon Replace Low-Dose Aspirin
Millions of people living with coronary artery disease could see a major shift in their daily treatment regimen.
Aspirin is commonly prescribed to patients with coronary artery disease to prevent heart attacks and strokes, but a new analysis has found that another drug, clopidogrel, is more effective and just as ...
Aspirin, long the go-to for heart protection, may be dethroned. New research reveals clopidogrel, a blood thinner, reduces major cardiovascular events ...
Researchers reported that clopidogrel should replace aspirin as a routine pill for preventing heart attacks and strokes for people with heart conditions.
Bristol-Myers Squibb and Sanofi’s Plavix was the top-selling drug in the first quarter of 2012, but it’s time on top may not last long. Bristol-Myers Squibb and Sanofi’s Plavix was the top-selling ...
NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer prasugrel works faster and could be more effective than the commonly used ...
BARCELONA (Reuters) - AstraZeneca's new pill Brilinta for preventing heart attacks works better than Plavix, the world's second biggest selling drug, without increasing the amount of life-threatening ...
BOSTON (MarketWatch) -- News that Bristol-Myers Squibb and partner Sanofi-Aventis may have successfully warded off early generic competition for their blockbuster drug Plavix stoked trading of drug ...
Doctors have found that the drug clopidogrel is more effective at preventing heart attacks and stroke in patients than aspirin.A new study presented at the European Society of Cardiology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results